Hosted on MSN
Evercore ISI Group Initiates Coverage of Beam Therapeutics (BEAM) with Outperform Recommendation
Fintel reports that on November 24, 2025, Evercore ISI Group initiated coverage of Beam Therapeutics (NasdaqGS:BEAM) with a Outperform recommendation. Analyst Price Forecast Suggests 111.58% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results